Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
2.
N Z Med J ; 100(825): 341-2, 1987 Jun 10.
Article in English | MEDLINE | ID: mdl-3330584

ABSTRACT

The susceptibility of urinary tract Escherichia coli isolates to cotrimoxazole, sulphonamide, trimethoprim, and ampicillin was monitored over an 11-year period. A trend in increasing resistance to cotrimoxazole and trimethoprim was observed, but there was no comparable alteration in sulphonamide resistance. Ampicillin resistance was high at the beginning of the survey period and continued to rise.


Subject(s)
Ampicillin Resistance , Anti-Infective Agents, Urinary/antagonists & inhibitors , Escherichia coli/drug effects , Sulfamethoxazole/antagonists & inhibitors , Sulfonamides/antagonists & inhibitors , Trimethoprim/antagonists & inhibitors , Urinary Tract/microbiology , Drug Combinations/antagonists & inhibitors , Drug Resistance, Microbial , Escherichia coli/isolation & purification , Humans , Microbial Sensitivity Tests , New Zealand , Time Factors , Trimethoprim, Sulfamethoxazole Drug Combination
3.
Orthop Rev ; 16(4): 255-8, 1987 Apr.
Article in English | MEDLINE | ID: mdl-3331735

ABSTRACT

Osteomyelitis is becoming a more common infection. This increase has been associated with an increase in the number of orthopaedic surgical procedures and with severe bone trauma. The etiology of osteomyelitis is also changing, with more gram-negative and more polymicrobial infections due to both gram-positive and gram-negative pathogens. Underlying diseases such as diabetes mellitus, peripheral vascular and sickle cell disease are associated with a poor cure rate when treated with antibiotics. The emergence of resistant strains of bacteria during the long-term treatment necessary for osteomyelitis has been documented, and continues to be a concern, as are the other side effects.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Osteomyelitis/drug therapy , Adult , Ceftazidime/therapeutic use , Clavulanic Acids/antagonists & inhibitors , Drug Combinations/antagonists & inhibitors , Humans , Staphylococcal Infections/drug therapy , Ticarcillin/antagonists & inhibitors , beta-Lactamase Inhibitors
4.
Clin Neuropharmacol ; 9(6): 542-8, 1986.
Article in English | MEDLINE | ID: mdl-3802106

ABSTRACT

Treatment of migraine with ergot alkaloids may produce systemic vasospasm in patients, especially as a result of automedication and overconsumption but also due to individual hypersensitivity. Peripheral vasoconstriction may lead to gangrene of the extremities, necessitating amputation. Various treatments have been tried against ischemic complications during ergotism with varied and unpredictable results. We report two recent cases of severe acute peripheral ischemia due to ergotamine abuse successfully treated with continuous systemic sodium nitroprusside infusion. The doses used during intraarterial injection are well below those known to be toxic. Consequently, the adverse effects of cyanide toxicity can be avoided. We think that intraarterial infusion of sodium nitroprusside, associated with forced diuresis and the administration of hydroxycobalamin, constitutes the treatment of choice of extreme peripheral ischemia of ergotism.


Subject(s)
Ergotism/drug therapy , Ferricyanides/therapeutic use , Nitroprusside/therapeutic use , Adult , Caffeine/adverse effects , Caffeine/antagonists & inhibitors , Drug Combinations/adverse effects , Drug Combinations/antagonists & inhibitors , Ergotamine/adverse effects , Ergotamine/antagonists & inhibitors , Female , Humans , Infusions, Intra-Arterial , Nitroprusside/administration & dosage
5.
Hum Toxicol ; 5(1): 61-2, 1986 Jan.
Article in English | MEDLINE | ID: mdl-2936675

ABSTRACT

Although there is no generally accepted therapy for ergotamine-induced vasoconstriction, infusion of directly acting vasodilators is regarded presently as the treatment of choice. We present a case of peripheral arterial ischaemia secondary to excessive use of ergotamine suppositories, which was reversed with oral thymoxamine hydrochloride (an alpha 1-adrenoceptor antagonist) and ergotamine withdrawal. We suggest that in patients with ergotamine-induced peripheral arterial vasoconstriction with no evidence of gangrene, oral thymoxamine may be considered as a useful adjunct or possible alternative to infused vasodilator treatment.


Subject(s)
Caffeine/adverse effects , Ergotamine/adverse effects , Ischemia/chemically induced , Leg/blood supply , Moxisylyte/therapeutic use , Adult , Caffeine/administration & dosage , Caffeine/antagonists & inhibitors , Drug Combinations/administration & dosage , Drug Combinations/adverse effects , Drug Combinations/antagonists & inhibitors , Ergotamine/administration & dosage , Ergotamine/antagonists & inhibitors , Female , Humans , Ischemia/drug therapy , Paresthesia/chemically induced , Suppositories
7.
Eur J Clin Microbiol ; 3(5): 424-6, 1984 Oct.
Article in English | MEDLINE | ID: mdl-6238821

ABSTRACT

The practice of using sulfamethoxazole-trimethoprim (SXT) for the selective isolation of Streptococcus pyogenes and as a taxonomic character in the presumptive identification of streptococci was applied to 17 strains of different groups of streptococci to determine their characteristic behaviour in the presence of exogenous thymidine. Streptococcus pyogenes, Streptococcus agalactiae and group D enterococci utilized thymidine, the first two species obtaining a maximum reversal of the inhibitory effect of SXT at thymidine concentrations of 1.2 micrograms/ml and 0.6 micrograms/ml or higher, respectively. For group D enterococci, the degree of reversal of the inhibitory effect was proportional to the thymidine concentration. In contrast, the four viridans species studied (Streptococcus sanguis I, Streptococcus salivarius, Streptococcus mitis and Streptococcus sanguis II) and Streptococcus pneumoniae were unable to utilize thymidine from an exogenous source and thus growth remained inhibited even at the highest concentrations of thymidine tested. For selective isolation and identification of streptococci only stable media with batch-to-batch consistency are recommended together with a known quantity of thymidine.


Subject(s)
Anti-Bacterial Agents/antagonists & inhibitors , Caseins , Streptococcus/drug effects , Sulfamethoxazole/antagonists & inhibitors , Thymidine/pharmacology , Trimethoprim/antagonists & inhibitors , Agar , Anti-Bacterial Agents/pharmacology , Culture Media , Drug Combinations/antagonists & inhibitors , Drug Combinations/pharmacology , Folic Acid/metabolism , Protein Hydrolysates , Streptococcus/isolation & purification , Streptococcus/metabolism , Sulfamethoxazole/pharmacology , Trimethoprim/pharmacology , Trimethoprim, Sulfamethoxazole Drug Combination
8.
Biull Eksp Biol Med ; 98(8): 206-9, 1984 Aug.
Article in Russian | MEDLINE | ID: mdl-6466859

ABSTRACT

Intracerebroventricular injection of 1-kynurenine sulfate (10 micrograms) eliminated anticaffeine effect of diazepam (5, 10 and 20 mg/kg) in mice. Antipentylenetetrazole (0.5-2.5 mg/kg) and anticonflict (1-2.5 mg/kg) effects of diazepam were not altered by kynurenine (0.1-10 micrograms). The sedative effect of diazepam (1 and 4 mg/kg) was potentiated by kynurenine (1 microgram). Stimulation of locomotion induced by kynurenine (0.5 and 2.5 micrograms) was prevented or perversed by pretreatment with diazepam (1 mg/kg). In a conflict situation test, diazepam and kynurenine had an opposite action, respectively increasing and decreasing the number of transitions between light and dark compartments. The central effects of kynurenine can be related and not related to benzodiazepine receptors.


Subject(s)
Diazepam/pharmacology , Kynurenine/pharmacology , Animals , Benzoates/antagonists & inhibitors , Caffeine/antagonists & inhibitors , Conflict, Psychological , Dose-Response Relationship, Drug , Drug Combinations/antagonists & inhibitors , Drug Interactions , Drug Synergism , Injections, Intraperitoneal , Injections, Intraventricular , Mice , Mice, Inbred Strains , Pentylenetetrazole/antagonists & inhibitors , Reaction Time/drug effects , Seizures/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...